Avendus Group Advises OmniActive Health Technologies on Its Private Equity and Debt Fund Raising.

Mumbai based nutraceutical ingredient player OmniActive Health Technologies Ltd. concluded a round of private equity funding from Everstone Capital and debt funding from multiple sources including Avendus Finance Private Limited (AFPL), the credit solutions arm of Avendus Group.

OmniActive is a leading supplier of naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical companies that provide food supplements and nutritional fortification. OmniActive has a research-driven approach, state of the art manufacturing facilities, well-equipped R&D centres across India and Canada, and sales and marketing presence across the US, Europe and Asia.

Avendus Group was the sole financial advisor to OmniActive on this transaction.

Deal Value

Undisclosed

Service

Private Equity

Sector

Industrials

Date

January 2017

We welcome this partnership with reputed financial investors. With the support of their experienced teams and funding, OmniActive looks forward to building on our history of solid organic growth by further strengthening our presence globally using innovative products and technologies. This will be done by also growing inorganically, to bring a wider product portfolio of responsibly made ingredients to our customers through our strategic acquisitions.

Mr. Sanjaya Mariwala

Founder and Managing Director, Kancor

We believe that there is a large, growing, opportunity in the global nutraceutical space. OmniActive, with its strong R&D and technology platform, leadership positions in segments of choice, and a strong sales and marketing engine, is uniquely positioned to leverage on the opportunity. The partnership with Everstone gives OmniActive a strong runway to execute its growth plans.

Preet Mohan Singh

Executive Director & Head Industrials Group, Avendus Capital Pvt. Ltd.

Considering the size of the current opportunity and OmniActive’s future plans, a balanced capital structure was required to empower it to successfully pursue its growth strategy as well as keep the necessary flexibility for the future fund raising. We are happy to provide a solution in line with the desired outcomes for all stakeholders.

Sandeep Thapliyal

MD & CEO – AFPL

About OmniActive Health Technologies Limited | Everstone

OmniActive Health Technologies (www.omniactives.com) offers a range of quality ingredients that are innovative and scientifically validated to address complex challenges for customers in the dietary supplement, food and beverage space using technology-driven, sustainable solutions with application support within a global regulatory framework. OmniActive’s core products include carotenoids, plant extracts and specialty functional ingredients. The company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies. OmniActive leverages international R&D strengths to deploy an array of state of the art manufacturing technologies in extraction, purification, isolation and delivery of nutritional actives. Clinical research–geared towards demonstrating efficacy and claim substantiation–is the cornerstone of OmniActive’s R&D activities. The company’s centres of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India. Whether looking for a new ingredient to add to a finished product, or technology to enhance an existing ingredient, OmniActive delivers unmatched innovation.

The Everstone Group is a premier India and Southeast Asia focused private equity and real estate investment firm with assets under management of USD 3.3 billion. Everstone has over 200 people working across six offices—Singapore, Mumbai, Delhi, Bengaluru, Mauritius and London. The firm’s strong presence and network in India and Southeast Asia allows its existing and new portfolio businesses to build operations in the region and beyond. Everstone has been awarded ‘Private Equity Firm of the Year in India’ by Private Equity International for five consecutive years from 2011 to 2015.